...
首页> 外文期刊>RSC Advances >Folate chitosan conjugated doxorubicin and pyropheophorbide acid nanoparticles (FCDP–NPs) for enhance photodynamic therapy
【24h】

Folate chitosan conjugated doxorubicin and pyropheophorbide acid nanoparticles (FCDP–NPs) for enhance photodynamic therapy

机译:叶酸壳聚糖偶联的阿霉素和焦脱镁叶酸纳米颗粒(FCDP-NPs)增强光动力治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We prepared new folate chitosan conjugated doxorubicin (DOX) and pyropheophorbide acid (PPa) nanoparticles (FCDP–NPs) using an ionic gelation method with tripolyphosphate (TPP) to enhance photodynamic therapy activity, based on the considerations of the long absorption wavelength (683 nm) of pyropheophorbide acid (PPa) in water and the excellent chemotherapeutic characteristics of doxorubicin (DOX) in cancer therapy. The obtained FCDP–NPs demonstrated a typical spherosome structure, a strong near infrared (NIR) absorption (705 nm) and significantly improved stability and dispersity in PBS (pH = 5, 7, 9); as well as a high singlet oxygen quantum yield (ΦΔ = 64%) compared to free PPa (ΦΔ = 59.1%). In addition, the in vitro cell experiments suggested that FCDP–NPs could be uptaken by HepG2 cells quickly and were mainly located in the cell nucleus. FCDP–NPs showed improved PDT efficiency over pure PPa and DOX at the same concentration after irradiation. Specifically, FCDP–NPs could lead to a 92% inhibition rate on HepG2 cells at 40 μg mL?1 (equal to 6 μg mL?1 DOX). However, the pure DOX showed little cytotoxicity at 6 μg mL?1, which suggests that a small amount of DOX could effectively enhance the PDT activities of PPa and lead to little “dark” cytotoxicity. Moreover, cell morphological changes after PDT treatment further indicated that FCDP–NPs could induce damage and apoptotic cell death efficiently. Finally, the photochemical mechanism of FCDP–NPs during PDT process was investigated by using specific quenching agents sodium azide (SA, a single oxygen quencher) and D-mannitol (DM, a hydroxyl radicals quencher), respectively. The results suggested that Type I and Type II photodynamic reactions can occur simultaneously, yet Type I reaction (the generation of hydroxyl radicals) might play a more important role. All these studies indicated that the FCDP–NPs could be potential nanoparticles in photodynamic cancer treatment.
机译:基于长吸收波长(683 nm)的考虑,我们采用离子凝胶法结合三聚磷酸酯(TPP)制备了新的叶酸壳聚糖共轭阿霉素(DOX)和焦脱镁叶酸(PPDP)纳米颗粒(FCDP–NPs)。 )中的焦脱镁叶绿酸(PPa)和阿霉素(DOX)在癌症治疗中的优异化学治疗特性。获得的FCDP-NPs具有典型的球体结构,近红外(NIR)吸收强(705 nm)并显着改善了PBS中的稳定性和分散性(pH = 5、7、9)。与游离PPa(Φ)相比,单线态氧量子产率高(Φ Δ = 64%) Δ = 59.1%)。此外,体外细胞实验表明,FCDP-NPs可以被HepG2细胞快速摄取,并且主要位于细胞核中。在辐照后相同浓度下,FCDP-NPs的PDT效率优于纯PPa和DOX。具体来说,当浓度为40μgmL ?1 (等于6μgmL ?1)时,FCDP–NPs可能对HepG2细胞产生92%的抑制率 DOX)。但是,纯的DOX在6μgmL ?1 时几乎没有细胞毒性,这表明少量的DOX可以有效地增强PPa的PDT活性,并且几乎不产生“黑暗”的细胞毒性。此外,PDT处理后的细胞形态变化进一步表明,FCDP-NPs可以有效地诱导损伤和凋亡细胞死亡。最后,分别通过使用特定的淬灭剂叠氮化钠(SA,一种氧气淬灭剂)和 D 甘露醇(DM,一种羟基自由基淬灭剂)研究了FCDP-NPs在PDT过程中的光化学机理。 。结果表明,I型和II型光动力反应可以同时发生,但I型反应(羟基自由基的产生)可能起着更重要的作用。所有这些研究表明,FCDP-NP在光动力癌症治疗中可能是潜在的纳米颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号